Azura Ophthalmics
Latest round
- Series C
Last raised
- Oct 2020
Total raised
- $30M
Investors
- 5
About Azura Ophthalmics
Azura Ophthalmics Ltd.Founded in 2014, Azura Ophthalmics Ltd. is based in Tel Aviv-Yafo, Israel, and is dedicated to addressing ocular surface diseases.Azura Ophthalmics specializes in developing a new class of therapies known as Ophthalmic Keratolytics, targeting ocular surface diseases. Their core product offerings focus on treating lid margin and ocular surface conditions by addressing the underlying pathophysiology, ultimately aiming to alleviate the signs and symptoms associated with these diseases. These innovative treatments are designed to revolutionize the management of ophthalmic conditions, particularly for patients who currently have limited options. Azura Ophthalmics actively engages with healthcare providers, ophthalmologists, and patients as part of their client base, ensuring that these advanced therapies reach those in need.The financial model of Azura Ophthalmics is structured around direct sales of their Ophthalmic Keratolytics to healthcare providers and institutions specializing in eye care. The company engages in B2B transactions, establishing partnerships with medical distributors and wholesalers to facilitate the distribution of their products. These transactions involve pricing structures based on bulk purchases and contractual agreements with healthcare facilities, ensuring a steady supply of their therapeutic offerings. The flagship products, integral to Azura’s portfolio, are expected to contribute significantly to the company's revenue stream as they gain market traction. Additionally, the company plans to explore specific global market expansions, with targeted geographical regions to increase the accessibility of their innovative therapies.
Who invested in Azura Ophthalmics
5 investors across 2 rounds
See all investors in Azura Ophthalmics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Azura Ophthalmics
Who invested in Azura Ophthalmics?
Azura Ophthalmics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Azura Ophthalmics raised?
Azura Ophthalmics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Azura Ophthalmics last raise money?
Azura Ophthalmics's most recent round on record is a Series C, in Oct 2020.
What does Azura Ophthalmics do?
Azura Ophthalmics is a healthcare specialists company.
Where is Azura Ophthalmics headquartered?
Azura Ophthalmics is headquartered in Tel Aviv-Yafo, Israel.
Which VCs invest in companies like Azura Ophthalmics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Azura Ophthalmics's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like Azura Ophthalmics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.